The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration ... its subdermal semaglutide implant under development for chronic weight management in obese ...

A woman is clapping back at critics after receiving body-shaming comments despite having success in her weight loss journey.

The average weight for women in the U.S. is 170.8 pounds, and the average height is 5 feet, 3 inches tall. These are ...

Despite the current downward trend of NVO, it is a good stock to add to one's portfolio for long-term gains due to strong ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

Mounjaro is similar to Ozempic and Wegovy — brand names for semaglutide — which work in the brain to impact satiety and result in weight loss. Bridget shared photos of her impressive physical ...

GEMMA Collins has today revealed the horrifyingly cruel nickname she was called before going on fat jabs. The TV favourite, ...

In its annual 'Measuring the Return from Pharmaceutical Innovation' report based on the top 20 pharma companies by 2020 R&D ...

Not long ago, the FDA announced there's no longer a shortage of Ozempic, Wegovy, Zepbound or similar drugs used for weight ...